<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font15 { font-size : 15; } .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font22 { font-size : 22; } .font23 { font-size : 23; } .font28 { font-size : 28; } .font31 { font-size : 31; }</style>
 <body>
  <p>
   <span class="font31">risk </span>
   <span class="font28">patients </span>
   <span class="font23">bleeding </span>
   <span class="font22">VTE </span>
   <span class="font21">anticoagulation </span>
   <span class="font20">dose </span>
   <span class="font20">COVID- </span>
   <span class="font20">DVT </span>
   <span class="font20">low </span>
   <span class="font20">score </span>
   <span class="font20">patient </span>
   <span class="font19">imaging </span>
   <span class="font18">diagnosis </span>
   <span class="font18">{border-style </span>
   <span class="font17">px;} </span>
   <span class="font17">#ffffff;} </span>
   <span class="font17">Table </span>
   <span class="font17">lower </span>
   <span class="font17">venous </span>
   <span class="font16">high </span>
   <span class="font16">treatment </span>
   <span class="font16">duplex </span>
   <span class="font16">empiric </span>
   <span class="font16">use </span>
   <span class="font16">vascular </span>
   <span class="font15">Wells </span>
   <span class="font15">ill </span>
   <span class="font15">pulmonary </span>
   <span class="font15">suspected </span>
   <span class="font15">critically </span>
   <span class="font14">Wellsâ€™ </span>
   <span class="font14">clinical </span>
   <span class="font14">recommend </span>
   <span class="font14">Patient </span>
   <span class="font14">care </span>
   <span class="font14">extremity </span>
   <span class="font14">treated </span>
   <span class="font13">expected </span>
   <span class="font13">heparin </span>
   <span class="font13">modified </span>
   <span class="font13">probability </span>
   <span class="font13">thrombosis </span>
   <span class="font13">associated </span>
   <span class="font13">pandemic </span>
   <span class="font13">px; </span>
   <span class="font13">thromboprophylaxis </span>
   <span class="font13">ultrasonography </span>
   <span class="font13">{font-family </span>
   <span class="font13">&amp;lt; </span>
   <span class="font13">PE. </span>
   <span class="font13">Score </span>
   <span class="font13">Venous </span>
   <span class="font13">data </span>
   <span class="font13">diagnostic </span>
   <span class="font13">following </span>
   <span class="font13">font-size </span>
   <span class="font13">setting </span>
   <span class="font13">time </span>
   <span class="font12">Surg </span>
   <span class="font12">Vasc </span>
   <span class="font12">Wang </span>
   <span class="font12">available </span>
   <span class="font12">based </span>
   <span class="font12">clinician </span>
   <span class="font12">current </span>
   <span class="font12">double; </span>
   <span class="font12">elevated </span>
   <span class="font12">given </span>
   <span class="font12">healthcare </span>
   <span class="font12">intubated </span>
   <span class="font12">mortality </span>
   <span class="font12">recognizing </span>
   <span class="font12">resource </span>
   <span class="font12">scan </span>
   <span class="font12">severe </span>
   <span class="font12">study </span>
   <span class="font12">Clinical </span>
   <span class="font12">D-dimer </span>
   <span class="font12">Elsevier </span>
   <span class="font12">Health </span>
   <span class="font12">algorithms </span>
   <span class="font12">border-color </span>
   <span class="font12">border-width </span>
   <span class="font12">cancer </span>
   <span class="font12">change </span>
   <span class="font12">committee </span>
   <span class="font12">consideration </span>
   <span class="font12">critical </span>
   <span class="font12">deep </span>
   <span class="font12">diagnosis. </span>
   <span class="font12">dimer </span>
   <span class="font12">follow </span>
   <span class="font12">likely </span>
   <span class="font12">long </span>
   <span class="font12">negative </span>
   <span class="font12">obligation </span>
   <span class="font12">positive </span>
   <span class="font12">previous </span>
   <span class="font12">protocols </span>
   <span class="font12">ratio </span>
   <span class="font12">risk-benefit </span>
   <span class="font12">solid; </span>
   <span class="font12">term </span>
   <span class="font12">therapy </span>
   <span class="font12">thromboembolism </span>
   <span class="font12">ultrasound </span>
   <span class="font12">upper </span>
   <span class="font12">{font-style </span>
   <span class="font12">{font-weight </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">(or </span>
   <span class="font11">ACS </span>
   <span class="font11">Algorithm </span>
   <span class="font11">DVT. </span>
   <span class="font11">Disord </span>
   <span class="font11">Figure </span>
   <span class="font11">Figures </span>
   <span class="font11">Lancet </span>
   <span class="font11">Low </span>
   <span class="font11">Lymphat </span>
   <span class="font11">Med </span>
   <span class="font11">Note </span>
   <span class="font11">Patients </span>
   <span class="font11">VTE-BLEED </span>
   <span class="font11">Vascular </span>
   <span class="font11">acute </span>
   <span class="font11">admitted </span>
   <span class="font11">anticoagulants </span>
   <span class="font11">anticoagulation. </span>
   <span class="font11">anticoagulation; </span>
   <span class="font11">appropriate </span>
   <span class="font11">bleeding, </span>
   <span class="font11">bold </span>
   <span class="font11">centre </span>
   <span class="font11">considered </span>
   <span class="font11">courier; </span>
   <span class="font11">em; </span>
   <span class="font11">embolism </span>
   <span class="font11">embolism; </span>
   <span class="font11">evidence </span>
   <span class="font11">existing </span>
   <span class="font11">experience </span>
   <span class="font11">extremity; </span>
   <span class="font11">factors </span>
   <span class="font11">hospitals </span>
   <span class="font11">inpatient </span>
   <span class="font11">institutional </span>
   <span class="font11">major </span>
   <span class="font11">management </span>
   <span class="font11">moral </span>
   <span class="font11">morbidity </span>
   <span class="font11">need </span>
   <span class="font11">patient; </span>
   <span class="font11">patients, </span>
   <span class="font11">patients. </span>
   <span class="font11">performed </span>
   <span class="font11">pneumonia </span>
   <span class="font11">practice </span>
   <span class="font11">pre-test </span>
   <span class="font11">pretest </span>
   <span class="font11">provide </span>
   <span class="font11">pt;} </span>
   <span class="font11">risk, </span>
   <span class="font11">studies </span>
   <span class="font11">thromboembolism; </span>
   <span class="font11">used </span>
  </p>
 </body>
</html>
